Novartis AG (NVS) Stock
Healthcare · Drug Manufacturers - General · CH
$156.15
-1.45%
Last updated Aug 3, 2026 04:31 UTC
NVS Key Statistics
Market Cap$296.80B
P/E (TTM)23.55
P/S (TTM)5.33
P/B (TTM)7.07
Revenue (TTM)$55.63B
EPS (TTM)$6.63
Dividend Yield2.70%
ROE (TTM)29.64%
Net Margin23.09%
Gross Margin74.29%
52W High$170.46
52W Low$112.34
Analyst ViewHold
Price Target$170.00
Employees75,267
Volume1,265,334
About Novartis AG
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
CEO: Vas Narasimhan. Company website
See NVS live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open NVS in Terminal See plans